Abstract
Ilyes Zatla
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
openalex
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Hantaviruses
10.1016/j.cll.2010.01.004 · 2010
Hantaviruses: a short review
10.5858/2003-127-30-hasr · 2003
A brief history of bunyaviral family Hantaviridae
10.3390/diseases11010038 · 2023
HFRS after a wild rodent bite in the Haute-Savoie—and risk of exposure to Hantaan-like virus in a Paris laboratory
1984
Our Hantaan virus became a new family, Hantaviridae in the classification of order Bunyavirales. It will remain as a history of virology
10.4167/jbv.2019.49.2.45 · 2019
Unresolved referenced work
2026
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Epidemiology of hantavirus infections in humans: a comprehensive global overview
10.3109/1040841x.2013.783555 · 2014
A global perspective on hantavirus ecology, epidemiology, and disease
10.1128/cmr.00062-09 · 2010
Hemorrhagic fever with renal syndrome in Asia: history, pathogenesis, diagnosis, treatment, and prevention
10.3390/v15020561 · 2023
Unresolved referenced work
2026
Factors driving hantavirus emergence in Europe
10.1016/j.coviro.2013.01.002 · 2013
Hantavirus infections in Europe and their impact on public health
10.1002/rmv.1722 · 2013
Hantavirus research in Finland: highlights and perspectives
10.3390/v13081452 · 2021
Population-based seroprevalence of Puumala hantavirus in Finland: smoking as a risk factor
10.1017/s0950268817002904 · 2018
Hantavirus disease (nephropathia epidemica) in Belgium: effects of tree seed production and climate
10.1017/s0950268808000940 · 2009
Detection of Dobrava hantavirus RNA in Apodemus mice in Bulgaria
10.1002/jmv.24033 · 2015
Viral zoonoses in humans (zooanthroponoses) with similar clinical manifestation
2017
Clinical aspects of hantavirus infections in Bulgaria
10.1007/s00508-017-1174-2 · 2017
Hantaviruses in small mammals in two regions in Bulgaria
2021
Hantaviruses in the americas and their role as emerging pathogens
10.3390/v2122559 · 2010
10.2139/ssrn.6620250
10.2139/ssrn.6620250 · 2026
Hantavirus infection: a review and global update
10.3855/jidc.317 · 2008
The ecological dynamics of hantavirus diseases
10.1371/journal.pntd.0006901 · 2019
Hantaviruses and climate change
10.1111/j.1469-0691.2009.02848.x · 2009
Outbreaks of hantavirus induced by seasonality
10.1103/physreve.69.021906 · 2004
Hantavirus (Hantavirus spp.)
10.1002/9781119985853.ch7.1 · 2025
Zoonotic Hantaviridae with global public health significance
10.3390/v15081705 · 2023
Hantaviridae: current classification and future perspectives
10.3390/v11090788 · 2019
ICTV virus taxonomy profile: hantaviridae 2024
10.1099/jgv.0.001975 · 2024
Dobrava-Belgrade virus: phylogeny, epidemiology, disease
10.1016/j.antiviral.2012.05.011 · 2012
Hantavirus infections by Puumala or Dobrava-Belgrade virus in pregnant women
10.1016/j.jcv.2012.07.011 · 2012
Cyclic hantavirus epidemics in humans predicted by rodent host dynamics
10.1016/j.epidem.2009.03.002 · 2009
Hantavirus replication cycle—an updated structural virology perspective
10.3390/v13081561 · 2021
Hantavirus structure—molecular interactions behind the scene
10.1099/vir.0.042218-0 · 2012
High-resolution in situ structures of hantavirus glycoprotein tetramers
10.1016/j.cell.2026.01.030 · 2026
Hantavirus: an overview and advancements in therapeutic approaches for infection
10.3389/fmicb.2023.1233433 · 2023
Epidemiology, virology and clinical aspects of hantavirus infections: an overview
10.1080/09603123.2021.1917527 · 2022
Ecology of hantavirus in a changing world
2010
Hantaviruses: Bridging species, crossing borders
10.1201/9781003607816-5 · doi-reference
Exploring the Interplay of UV Index, Population Density, and SARS-CoV-2 Clades on COVID-19 Propagation: A Comprehensive Analysis of the Pandemic Dynamics
10.61186/iem.10.1.61 · doi-reference
Navigating the molecular diversity of SARS-CoV-2: Early pandemic insights from comparative phylogenetic analysis
10.5584/jiomics.v14i1.228 · doi-reference
Hantavirus: Third British national has suspected infection as WHO says this is “not the start of a pandemic
10.1136/bmj.s899 · doi-reference
Hantavirus: the next pandemic we are waiting for
10.1007/s12539-020-00413-4 · doi-reference
Assessment of COVID-19 vaccination performance in Tlemcen: Insights into vaccine inventory management
10.21608/mid.2025.307979.2112 · doi-reference
Profiling COVID-19 cases in Tlemcen, Algeria: PCR and CT imaging insights
10.3390/covid5090149 · doi-reference
COVID-19 in North Africa: An epidemiological analysis of cases, deaths, and vaccination efforts, (2020-2023)
10.61186/iem.9.4.349 · doi-reference
Tracing the origin and early progression of COVID-19 in Europe: An epidemiological descriptive study
10.61186/iem.9.3.249 · doi-reference
Assessing the knowledge of smallpox and monkeypox virus among the University of Tlemcen members in the wake of COVID-19: A 2023 cross-sectional study
10.21010/ajidv18i1.2 · doi-reference
Unveiling monkeypox virus emergence: What unfolded in the aftermath of the COVID-19 threat
10.31300/ctimm.24.2023.9-20 · doi-reference
Re-emergence of monkeypox: a post-COVID-19 challenge
10.31300/ctimm.24.2023.21-29 · doi-reference
Molecular evolution of Puumala hantavirus
10.1128/jvi.75.23.11803-11810.2001 · doi-reference
Evolution of hantaviruses: co-speciation with reservoir hosts for more than 100 MYR
10.1016/j.virusres.2014.01.008 · doi-reference
Hantaviruses: Molecular biology, evolution and pathogenesis
10.2174/156652405774962317 · doi-reference
The evolution and emergence of hantaviruses
10.1016/j.coviro.2014.12.007 · doi-reference
What is the time-scale of hantavirus evolution
10.1016/j.meegid.2014.04.017 · doi-reference
New ecological aspects of hantavirus infection: a change of a paradigm and a challenge of prevention-a review
10.1007/s11262-004-5625-2 · doi-reference
Hantavirus infections and their prevention
10.1016/s1286-4579(01)01474-5 · doi-reference
Hantavirus infections—treatment and prevention
10.1007/s40506-020-00236-3 · doi-reference
Progress on the prevention and treatment of hantavirus disease
10.3390/v11070610 · doi-reference
Vaccines for hantaviruses
10.1016/j.vaccine.2009.07.096 · doi-reference
Protective effectiveness of hantavirus vaccine
10.3201/eid1012.040684 · doi-reference
Protective effectiveness of inactivated hantavirus vaccine against hemorrhagic fever with renal syndrome
10.1093/infdis/jiy037 · doi-reference
Immune response during hantavirus diseases: implications for immunotherapies and vaccine design
10.1111/imm.13322 · doi-reference
A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS)
10.1016/j.vaccine.2013.07.025 · doi-reference
Recent approaches in hantavirus vaccine development
10.1586/14760584.8.1.67 · doi-reference
A computational study on gold and silver nanoparticles against SARS-coV-2 proteins
10.3390/proceedings2024103023 · doi-reference
Green-synthesized colloidal metal–β-escin bioconjugates for nasal delivery: A hypothetical prophylactic and therapeutic product against SARS-coV-2 variants
10.48048/tis.2025.9826 · doi-reference
Battling COVID-19 leveraging nanobiotechnology: Gold and silver nanoparticle–β-escin conjugates as SARS-CoV-2 inhibitors
10.1515/biol-2022-1047 · doi-reference
Enhanced nanobiotechnological strategy against SARS-coV-2: synergistic potential of rutin
10.2174/0126667975464024260213054706 · doi-reference
Hantavirus in humans: a review of clinical aspects and management
10.1016/s1473-3099(23)00128-7 · doi-reference
Pathophysiology of a severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant
10.3109/00365548.2012.755268 · doi-reference
Two point mutations in protocadherin-1 disrupt hantavirus recognition and afford protection against lethal infection
10.1038/s41467-023-40126-y · doi-reference
Long-term consequences of Puumala hantavirus infection
10.3390/v14030598 · doi-reference
Effectiveness of ribavirin in treatment of hantavirus infections in the Americas and Eurasia: a meta-analysis
10.1007/s13337-014-0219-7 · doi-reference
Vaccines and therapeutics against hantaviruses
10.3389/fmicb.2019.02989 · doi-reference
How to diagnose hantavirus infections and detect them in rodents and insectivores
10.1002/rmv.581 · doi-reference
Diagnostic rapid tests for acute hantavirus infections: specific tests for Hantaan, Dobrava and Puumala viruses versus a hantavirus combination test
10.1016/s0166-0934(02)00282-3 · doi-reference
Laboratory diagnosis of human hantavirus infection: novel insights and future potential
10.2217/fvl.09.15 · doi-reference